CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

autologous stromal vascular fraction

Cell therapyexperimental

Clinical trial activity

21 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
14
Phase 2
10
Phase 3
0
Phase 4
0

Earliest trial started Jun 1, 2013 (NCT01885819)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Unspecified targetTissue restoration

    Tissue restoration

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • autologous stromal vascular fraction
  • autologous stromal vascular fraction cells
  • cellular stromal vascular fraction

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05857358Phase 1/Phase 2 (Phase 2)Jan 31, 2024Aix-University of Marseille
NCT05708430Phase 2Apr 1, 2023Rouen Normandy University
NCT05515523Early Phase 1 (Phase 1)Jan 31, 2023Wake Forest University
NCT05354544Phase 1Nov 30, 2022Mayo Clinic
NCT05385159Phase 2Sep 22, 2022Aix-University of Marseille
NCT06304623Phase 1May 5, 2020government of nicaragua, National Autonomous University of Nicaragua, Wake Forest University
NCT04014244N/ASep 1, 2019University of Ljubljana
NCT03792360Phase 1Jul 1, 2019Mayo Clinic
NCT03940950Phase 1Jun 1, 2019Mayo Clinic
NCT03939741Phase 1/Phase 2 (Phase 2)Apr 1, 2019Bangladesh Laser & Cell Surgery Institute & Hospital
NCT03514537N/AMar 15, 2018Healeon Medical Inc
NCT03090672N/AMar 11, 2017GARM USA, Global Alliance for Regenerative Medicine, Regeneris Medical
NCT02975960N/AOct 1, 2016Catholic University of Korea
NCT02827851Phase 2May 31, 2016Government of Russia
NCT02704299Early Phase 1 (Phase 1)Mar 1, 2016Cellular Biomedicine Group Ltd., Peking University
NCT02741362Phase 1Dec 31, 2015University of Arkansas
NCT02846675Phase 1/Phase 2 (Phase 2)May 1, 2015Huazhong University of Science and Technology
NCT02145897Phase 1/Phase 2 (Phase 2)Aug 1, 2014Bharat Biotech International Limited, Jaslok Hospital and Research Centre, Mumbai, India, Kokilaben Dhirubai Ambani Hospital, Lokmanya Tilak Municipal Medical College, SL Raheja Hospital
NCT02135380Phase 1/Phase 2 (Phase 2)Aug 1, 2014Bharat Biotech International Limited, Bharti Hospital, Bombay Hospital & Medical Research Center, Cumballa Hill Hospital And Heart Institute, P.D. Hinduja Hospital and Medical Research Centre, Mumbai
NCT07259993Phase 1/Phase 2 (Phase 2)Aug 27, 2013University of California, San Francisco, Wake Forest University
Showing 20 of 21 trials
Page 1 / 2

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Mayo ClinicAcademic/Hospital3312019
Wake Forest UniversityAcademic/Hospital3322013
Aix-University of MarseilleAcademic/Hospital2212022
Bharat Biotech International LimitedFor profit2212014
Bangladesh Laser & Cell Surgery Institute & HospitalAcademic/Hospital1112019
Bharti HospitalAcademic/Hospital1012014
Bombay Hospital & Medical Research CenterAcademic/Hospital1012014
Catholic University of KoreaAcademic/Hospital1112016
Cellular Biomedicine Group Ltd.For profit1112016
Cumballa Hill Hospital And Heart InstituteAcademic/Hospital1012014
GARM USAAcademic/Hospital1012017
Global Alliance for Regenerative MedicineAcademic/Hospital1012017
government of nicaraguaAcademic/Hospital1012020
Government of RussiaGovernment1112016
Healeon Medical IncFor profit1112018
Huazhong University of Science and TechnologyAcademic/Hospital1112015
Jaslok Hospital and Research Centre, Mumbai, IndiaAcademic/Hospital1012014
Kokilaben Dhirubai Ambani HospitalAcademic/Hospital1012014
Lokmanya Tilak Municipal Medical CollegeAcademic/Hospital1012014
National Autonomous University of NicaraguaAcademic/Hospital1012020
29 organizations
Page 1 / 2